Dynamic changes in autoantibody titers, rather than baseline levels, were more strongly associated with SSc trajectory. Proteomic signatures suggest lipid metabolism and oxidative stress as potential drivers, highlighting novel biomarkers and therapeutic targets for personalized SSc management.
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
大力的灵雁
Zzz
风吹麦田
dew
老福贵儿
Moonpie
昏睡的蟠桃
pluto
tiptip
畔畔
Alexa
缓慢怜菡
阿瑟
子车茗
微尘
小太阳在营业
hgy
ySX
lizishu
皖公网安备34019202002308